Cost-Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin-Resistant<i>Enterococcus</i>

Abstract

The excess costs of VRE bacteremia may justify the costs of preventive measures. The costs of VRE infections at other body sites, of deaths from untreatable infections, and of dissemination of genes for vancomycin resistance also help to justify the costs of implementing an effective control program.